QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)

Henry Schein Stock Price, News & Analysis (NASDAQ:HSIC)

$69.31
-0.23 (-0.33%)
(As of 12/4/2023 ET)
Compare
Today's Range
$68.82
$70.01
50-Day Range
$61.89
$74.52
52-Week Range
$60.01
$89.72
Volume
1.21 million shs
Average Volume
922,360 shs
Market Capitalization
$9.05 billion
P/E Ratio
20.63
Dividend Yield
N/A
Price Target
$79.38

Henry Schein MarketRank™ Stock Analysis

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
14.5% Upside
$79.38 Price Target
Short Interest
Healthy
2.69% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
0.07mentions of Henry Schein in the last 14 days
Based on 24 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.69%
From $4.57 to $5.15 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.56 out of 5 stars

Medical Sector

204th out of 952 stocks

Medical & Hospital Equipment Industry

2nd out of 3 stocks


HSIC stock logo

About Henry Schein Stock (NASDAQ:HSIC)

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

HSIC Stock Price History

HSIC Stock News Headlines

All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Is Henry Schein (HSIC) a Good Investment Opportunity?
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Henry Schein (NASDAQ:HSIC) Given Buy Rating at Stifel Nicolaus
These Analysts Slash Their Forecasts On Henry Schein After Q3 Results
What 5 Analyst Ratings Have To Say About Henry Schein
Q3 2023 Henry Schein Inc Earnings Call
Why Is Dental Supplier Henry Schein Stock Trading Higher Today?
See More Headlines
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
12/04/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/15/2024

Industry, Sector and Symbol

Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Sector
Medical
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
22,000
Year Founded
1932

Price Target and Rating

Average Stock Price Target
$79.38
High Stock Price Target
$96.00
Low Stock Price Target
$65.00
Potential Upside/Downside
+14.5%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$538 million
Pretax Margin
4.66%

Debt

Sales & Book Value

Annual Sales
$12.65 billion
Cash Flow
$6.44 per share
Book Value
$30.21 per share

Miscellaneous

Free Float
129,096,000
Market Cap
$9.05 billion
Optionable
Optionable
Beta
0.84

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report














HSIC Stock Analysis - Frequently Asked Questions

Should I buy or sell Henry Schein stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings
or view top-rated stocks.

What is Henry Schein's stock price target for 2024?

7 brokerages have issued twelve-month price targets for Henry Schein's shares. Their HSIC share price targets range from $65.00 to $96.00. On average, they anticipate the company's stock price to reach $79.38 in the next twelve months. This suggests a possible upside of 14.5% from the stock's current price.
View analysts price targets for HSIC
or view top-rated stocks among Wall Street analysts.

How have HSIC shares performed in 2023?

Henry Schein's stock was trading at $79.87 at the beginning of 2023. Since then, HSIC stock has decreased by 13.2% and is now trading at $69.31.
View the best growth stocks for 2023 here
.

Are investors shorting Henry Schein?

Henry Schein saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 3,460,000 shares, an increase of 39.0% from the October 31st total of 2,490,000 shares. Based on an average daily volume of 996,600 shares, the days-to-cover ratio is presently 3.5 days. Currently, 2.7% of the company's shares are short sold.
View Henry Schein's Short Interest
.

When is Henry Schein's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our HSIC earnings forecast
.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) released its quarterly earnings data on Monday, November, 13th. The company reported $1.32 earnings per share for the quarter, hitting the consensus estimate of $1.32. The company had revenue of $3.16 billion for the quarter, compared to analysts' expectations of $3.21 billion. Henry Schein had a net margin of 3.51% and a trailing twelve-month return on equity of 16.08%. The company's quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.15 earnings per share.
Read the conference call transcript
.

When did Henry Schein's stock split?

Henry Schein's stock split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were distributed to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its board has authorized a stock buyback plan on Thursday, August 18th 2022, which permits the company to buyback $400,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 4% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's board believes its stock is undervalued.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein updated its FY23 earnings guidance on Monday, November, 13th. The company provided EPS guidance of $4.43-4.71 for the period, compared to the consensus EPS estimate of $5.20. The company issued revenue guidance of down 1-3% yr/yr to ~$12.27-12.52 billion, compared to the consensus revenue estimate of $12.83 billion.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a number of institutional and retail investors. Top institutional investors include JPMorgan Chase & Co. (3.65%), American Century Companies Inc. (3.61%), Invesco Ltd. (3.36%), Perpetual Ltd (3.28%), Morgan Stanley (1.62%) and Massachusetts Financial Services Co. MA (1.32%). Insiders that own company stock include Bradford C Connett, David B Brous Jr, Deborah Derby, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Philip A Laskawy, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Henry Schein have any subsidiaries?
The following companies are subsidiares of Henry Schein: ACE Surgical Supply Co. Inc., ADS Florida, AUV Veterinary Services, Accord, Alpha Scientific, Arcade Dentaire, Arseus, Arseus Dental Solutions, Arseus Lab, Becker-Parkin Dental Supply, BioHorizons Inc., Butler Schein Animal Health, C&M Vetlink, Camlog USA Inc., DNA Anthos Impianti, Dental Cremer, Dental Trey, Elite Computer Italia, Exan Enterprises Inc., HS Brand Management LLC, HS TM Holdings LLC, HSFR Inc., Handpiece Parts & Repairs Inc., Henry Schein Europe Inc., Henry Schein Global Sourcing Inc., Henry Schein Latin America Pacific Rim Inc., Henry Schein Medical Systems Inc., Henry Schein Practice Solutions Inc., InSource Inc., Jorgen Kruuse, Lincoln Dental Supply, Logiciel Julie, Maddox Practice Group, Maravet, Marrodent, Medivet, Medka, Minerva Dental Limited, Modern Laboratory Services, NLS Animal Health, Noviko, Ortho Organizers, Ortho Technology, Prism Medical Products L.L.C., Prism Medical Products LLC, Project Helium Holdings LLC, Project Spartan Holdings Corp., RxWorks, SG Healthcare Corp., Sirona Direct, SmartPak Equine LLC, Software of Excellence, Sogim Grimouille, Southern Anesthesia & Surgical, S & S Discount Inc., TDSC Inc., The Exan Group, Veterinary Instrumentation, Vetstreet, W. & J. Dunlop, eAssist Inc., and scil animal care.
Read More
This page (NASDAQ:HSIC) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -